A L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) active pharmaceutical ingredient (API) in detail. Different forms of L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) DMFs exist exist since differing nations have different regulations, such as L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) DMF submitted to regulatory agencies in the US is known as a USDMF. L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) USDMF includes data on L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt) suppliers with USDMF on PharmaCompass.